(secondQuint)Augmenting Clozapine With Sertindole - SERCLOZ.

 Around 20 % of patients with schizophrenia are treatment-resistant.

 Clozapine is still the drug of choice for these patients but 2/3 will not respond adequately to clozapine.

 In the study clozapine treatment is augmented with sertindole.

 Patients are randomized to either clozapine or sertindole for 12 weeks and continue in a open-label study with sertindole for 12 weeks.

 The purpose of the open-label study is to determine whether clozapine dosage can be reduced due to the addition of sertindole.

.

 Augmenting Clozapine With Sertindole - SERCLOZ@highlight

The purpose of the study is to determine whether addition of sertindole to clozapine treatment can improve psychosis or the metabolic side-effects of clozapine in patients with treatment-resistant schizophrenia.

